|
|
Volumn 371, Issue 23, 2014, Pages 2239-2241
|
|
Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC THERAPY;
BACTERIAL ENDOCARDITIS;
BACTERIAL MENINGITIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
INFECTION RISK;
LETTER;
STREPTOCOCCUS BOVIS;
STRONGYLOIDIASIS;
ADULT;
CLINICAL TRIAL;
FEMALE;
INDUCTION CHEMOTHERAPY;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PILOT STUDY;
YOUNG ADULT;
ANTINEOPLASTIC AGENT;
ARSENIC;
RETINOIC ACID;
ADMINISTRATION, ORAL;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARSENIC;
FEMALE;
HUMANS;
INDUCTION CHEMOTHERAPY;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
TRETINOIN;
YOUNG ADULT;
|
|
EID: 84918789988
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1412035 Document Type: Letter |
|
Times cited : (80)
|
|
References (4)
|
